AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7898092 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilazapril (ACE inhibitor)
Number of subjects: 112
Study 7898092 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study 3110316 — intervention group
Group type: EXPERIMENTAL
Intervention: gelatine + Solcoseryl
Number of subjects: 300
Study 3110316 — intervention group
Group type: EXPERIMENTAL
Intervention: gelatine + Solcoseryl + propyl‐hydroxy‐benzoic‐acid
Number of subjects: 300
Study 3110316 — intervention group
Group type: COMPARATOR
Intervention: gelatine
Number of subjects: 300
Study 29771194 — intervention group
Group type: EXPERIMENTAL
Intervention: +aPL
Number of subjects: 1208
Study 29771194 — intervention group
Group type: COMPARATOR
Intervention: -aPL
Number of subjects: 1208
Study 29771194 — intervention group
Group type: EXPERIMENTAL
Intervention: +aCL IgM
Number of subjects: 1208
Study 29771194 — intervention group
Group type: EXPERIMENTAL
Intervention: two positive aPL
Number of subjects: 1208
Study 29771194 — intervention group
Group type: EXPERIMENTAL
Intervention: +a‐β2‐I IgM
Number of subjects: 1208
Study 26925492 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss intervention (8 weeks duration)
Number of subjects: 26
Study 25514667 — intervention group
Group type: EXPERIMENTAL
Intervention: ICP-targeted treatment
Number of subjects: 105
Study 25514667 — intervention group
Group type: COMPARATOR
Intervention: Standard intensive care (control)
Number of subjects: 105
Study 23290985 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg q4w
Number of subjects: 274
Study 23290985 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg q2w or 300 mg q4w or 150 mg q4w
Number of subjects: 274
Study 23290985 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab (all doses)
Number of subjects: 274
Study 23290985 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 274
Study 20610788 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong elliptic velocity profile motor training
Number of subjects: 0
Study 20610788 — intervention group
Group type: EXPERIMENTAL
Intervention: Weak elliptic velocity profile motor training
Number of subjects: 0
Study 20610788 — intervention group
Group type: COMPARATOR
Intervention: Control group with linear trajectories
Number of subjects: 0
Study 18206950 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg vardenafil daily for 6 months
Number of subjects: 200
Study 18206950 — intervention group
Group type: COMPARATOR
Intervention: 100 mg sildenafil daily for 6 months
Number of subjects: 200
Study 18206950 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 16311189 — intervention group
Group type: EXPERIMENTAL
Intervention: Analogy learning condition
Number of subjects: 0
Study 16311189 — intervention group
Group type: EXPERIMENTAL
Intervention: Errorless learning condition
Number of subjects: 0
Study 16311189 — intervention group
Group type: EXPERIMENTAL
Intervention: Discovery learning condition
Number of subjects: 0
Study 16311189 — intervention group
Group type: COMPARATOR
Intervention: Concurrent verbal task
Number of subjects: 0
Study 14615726 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 mg per day of elemental iron as ferrous sulfate
Number of subjects: 77
Study 14615726 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 10771453 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziprasidone 80 mg
Number of subjects: 24
Study 10771453 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg
Number of subjects: 24
Study 10771453 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 8716423 — intervention group
Group type: EXPERIMENTAL
Intervention: Plaster checks performed by nurses
Number of subjects: 0
Study 8716423 — intervention group
Group type: COMPARATOR
Intervention: Plaster checks performed by doctors
Number of subjects: 0
Study 8716423 — intervention group
Group type: EXPERIMENTAL
Intervention: Institution of the process allowing nurses to perform plaster checks
Number of subjects: 0
Study 1571119 — intervention group
Group type: EXPERIMENTAL
Intervention: Ear canal disinfection with 70% alcohol or povidone‐iodine
Number of subjects: 157
Study 1571119 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of a bacterial pathogen in the ear canal
Number of subjects: 157
Study 1571119 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of a bacterial pathogen in the middle ear effusion
Number of subjects: 157
Study 1571119 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of inflamed middle ear mucosa at surgery
Number of subjects: 157
Study 1571119 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic antimicrobial treatment in children with inflamed middle ear mucosa or positive cultures
Number of subjects: 157
Study 4091238 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg methohexital/kg BW
Number of subjects: 66
Study 4091238 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg methohexital/kg BW
Number of subjects: 66
Study 4091238 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg methohexital/kg BW
Number of subjects: 66
Study 4091238 — intervention group
Group type: EXPERIMENTAL
Intervention: Methohexital plasma levels > 22 micrograms/ml
Number of subjects: 66
Study 31071355 — intervention group
Group type: EXPERIMENTAL
Intervention: Enlarged food units
Number of subjects: 185
Study 31071355 — intervention group
Group type: EXPERIMENTAL
Intervention: Unit-size increases
Number of subjects: 185
Study 31071355 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulating perceptual focus on size
Number of subjects: 185
Study 31071355 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulating perceptual focus on number
Number of subjects: 185
Study 30006015 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin (10 mg/day)
Number of subjects: 0
Study 30006015 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30006015 — intervention group
Group type: EXPERIMENTAL
Intervention: APOE ε4 carriers
Number of subjects: 0
Study 30006015 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-ε4 carriers
Number of subjects: 0
Study 29281208 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-track surgery (FTS) nursing care
Number of subjects: 200
Study 24768678 — intervention group
Group type: EXPERIMENTAL
Intervention: 1760 mcg daily fluticasone propionate (FP) for 3 months
Number of subjects: 42
Study 24768678 — intervention group
Group type: EXPERIMENTAL
Intervention: 880 mcg daily fluticasone propionate (FP) after initial CR
Number of subjects: 42
Study 24768678 — intervention group
Group type: EXPERIMENTAL
Intervention: 1760 mcg daily fluticasone propionate (FP) for 3 additional months for non-responders
Number of subjects: 42
Study 24768678 — intervention group
Group type: EXPERIMENTAL
Intervention: 1760 mcg daily fluticasone propionate (FP)
Number of subjects: 42
Study 24768678 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 23364563 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothguide Training (TT) for group A
Number of subjects: 94
Study 23364563 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothguide Training Box (TTB) for group B
Number of subjects: 94
Study 23364563 — intervention group
Group type: COMPARATOR
Intervention: Before training for both groups
Number of subjects: 94
Study 23364563 — intervention group
Group type: COMPARATOR
Intervention: After training for both groups
Number of subjects: 94
Study 20225213 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass-ionomer cement
Number of subjects: 112
Study 20225213 — intervention group
Group type: COMPARATOR
Intervention: Composite resin
Number of subjects: 112
Study 17711511 — intervention group
Group type: EXPERIMENTAL
Intervention: TRIMprob
Number of subjects: 200
Study 17711511 — intervention group
Group type: EXPERIMENTAL
Intervention: TRIMprob combined with DRE findings
Number of subjects: 200
Study 14622077 — intervention group
Group type: EXPERIMENTAL
Intervention: 16-week treatments for depression
Number of subjects: 30
Study 10790350 — intervention group
Group type: EXPERIMENTAL
Intervention: Electron-beam CT (EBCT)
Number of subjects: 112
Study 10790350 — intervention group
Group type: COMPARATOR
Intervention: Coronary angiography
Number of subjects: 112
Study 10790350 — intervention group
Group type: COMPARATOR
Intervention: Intracoronary ultrasound (ICUS)
Number of subjects: 112
Study 8737129 — intervention group
Group type: EXPERIMENTAL
Intervention: Sparfloxacin (200 mg loading dose followed by 100 mg once daily)
Number of subjects: 728
Study 8737129 — intervention group
Group type: COMPARATOR
Intervention: Amoxycillin/clavulanic acid (500 mg/125 mg tds)
Number of subjects: 728
Study 8737129 — intervention group
Group type: EXPERIMENTAL
Intervention: Sparfloxacin
Number of subjects: 728
Study 8737129 — intervention group
Group type: COMPARATOR
Intervention: Amoxycillin/clavulanic acid
Number of subjects: 728
Study 1396434 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ) monotherapy
Number of subjects: 40
Study 1396434 — intervention group
Group type: COMPARATOR
Intervention: Polytherapy (continuation of presurgical polytherapy)
Number of subjects: 40
Study 3883815 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline plus perphenazine
Number of subjects: 51
Study 3883815 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline alone
Number of subjects: 51
Study 3883815 — intervention group
Group type: COMPARATOR
Intervention: Perphenazine alone
Number of subjects: 51
Study 31366683 — intervention group
Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 56
Study 31366683 — intervention group
Group type: EXPERIMENTAL
Intervention: General Anesthesia plus Local Anesthesia (GA + LA)
Number of subjects: 56
Study 27993489 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary intervention targeting frailty (12-month duration)
Number of subjects: 241
Study 27993489 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 241
Study 26345362 — intervention group
Group type: EXPERIMENTAL
Intervention: Three sessions of breathing training (hour-long sessions at weekly intervals)
Number of subjects: 156
Study 26345362 — intervention group
Group type: COMPARATOR
Intervention: Single session of breathing training (one hour-long session)
Number of subjects: 156
Study 26345362 — intervention group
Group type: EXPERIMENTAL
Intervention: Three sessions of breathing training
Number of subjects: 156
Study 26345362 — intervention group
Group type: COMPARATOR
Intervention: Single session of breathing training
Number of subjects: 156
Study 24006873 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone reminders and information
Number of subjects: 181
Study 24006873 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminder letters and information booklets
Number of subjects: 181
Study 24006873 — intervention group
Group type: COMPARATOR
Intervention: Control group (no reminders or information)
Number of subjects: 181
Study 21835220 — intervention group
Group type: EXPERIMENTAL
Intervention: Trivalent FluBlok vaccine (45 mcg of each rHA0 component)
Number of subjects: 4648
Study 21835220 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 4648
Study 21835220 — intervention group
Group type: EXPERIMENTAL
Intervention: Trivalent FluBlok vaccine
Number of subjects: 4648
Study 19153079 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 h infusion of 0.5 g of imipenem every 6 h for 24 h
Number of subjects: 9
Study 19153079 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 h infusion of 0.5 g of imipenem every 6 h for 24 h
Number of subjects: 9
Study 19153079 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 h infusion of 1 g of imipenem every 6 h for 24 h
Number of subjects: 9
Study 17683103 — intervention group
Group type: EXPERIMENTAL
Intervention: Intoxicated arguing couple
Number of subjects: 156
Study 17683103 — intervention group
Group type: COMPARATOR
Intervention: Sober arguing couple
Number of subjects: 156
Study 17683103 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal aggression
Number of subjects: 156
Study 17683103 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical aggression
Number of subjects: 156
Study 15364356 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol treatment
Number of subjects: 42
Study 15364356 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 42
Study 11317490 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute exacerbation of MS (n = 21)
Number of subjects: 77
Study 11317490 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic progressive MS (n = 27)
Number of subjects: 77
Study 11317490 — intervention group
Group type: COMPARATOR
Intervention: MS remission (n = 29)
Number of subjects: 77
Study 11317490 — intervention group
Group type: COMPARATOR
Intervention: Other neurological diseases (n = 25)
Number of subjects: 77
Study 8615360 — intervention group
Group type: EXPERIMENTAL
Intervention: RRR-alpha-tocopherol supplementation (1632 mg or 1200 IU/d) for 8 weeks
Number of subjects: 28
Study 8615360 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 1599717 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodic health examination recommendations provided on outpatient charts
Number of subjects: 29
Study 1599717 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 29
Study 6366684 — intervention group
Group type: EXPERIMENTAL
Intervention: Solcoseryl Eye-Gel
Number of subjects: 61
Study 6366684 — intervention group
Group type: COMPARATOR
Intervention: 2.4% cysteine eye-gel
Number of subjects: 61
Study 30616442 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (6 months)
Number of subjects: 12
Study 29308685 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 29308685 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg oral pregabalin
Number of subjects: 70
Study 26727408 — intervention group
Group type: EXPERIMENTAL
Intervention: Group cognitive-behavioral therapy (GCBT)
Number of subjects: 97
Study 26727408 — intervention group
Group type: COMPARATOR
Intervention: Topical steroid
Number of subjects: 97
Study 24996379 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.5 Fr sphincterotome group I
Number of subjects: 280
Study 24996379 — intervention group
Group type: COMPARATOR
Intervention: 5.5 Fr sphincterotome group II
Number of subjects: 280
Study 24996379 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall cannulation success including precut for failed cases in group I
Number of subjects: 280
Study 24996379 — intervention group
Group type: COMPARATOR
Intervention: Overall cannulation success including precut for failed cases in group II
Number of subjects: 280
Study 24996379 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossover and double GW techniques
Number of subjects: 280
Study 22021072 — intervention group
Group type: COMPARATOR
Intervention: Selective digestive decontamination (SDD)
Number of subjects: 5927
Study 22021072 — intervention group
Group type: COMPARATOR
Intervention: Selective oropharyngeal decontamination (SOD)
Number of subjects: 5927
Study 22021072 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 5927
Study 20863994 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevelamer
Number of subjects: 100
Study 20863994 — intervention group
Group type: COMPARATOR
Intervention: Calcium acetate
Number of subjects: 100
Study 18484600 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness Based Stress Reduction (MBSR; n=15)
Number of subjects: 44
Study 18484600 — intervention group
Group type: EXPERIMENTAL
Intervention: Eight Point Program (EPP; n=14)
Number of subjects: 44
Study 18484600 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (n=15)
Number of subjects: 44
Study 15998659 — intervention group
Group type: EXPERIMENTAL
Intervention: FAT infusion (long-chain triglyceride emulsion, 2.8 kcal/min)
Number of subjects: 16
Study 15998659 — intervention group
Group type: COMPARATOR
Intervention: FAT‐THL (120 mg tetrahydrolipstatin, lipase inhibitor)
Number of subjects: 16
Study 12527979 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 g of glucose ingested 45 min prior to exercise
Number of subjects: 8
Study 10656432 — intervention group
Group type: EXPERIMENTAL
Intervention: Melphalan 20 mg/m2 (n = 5)
Number of subjects: 21
Study 10656432 — intervention group
Group type: EXPERIMENTAL
Intervention: Melphalan 30 mg/m2 (n = 7)
Number of subjects: 21
Study 10656432 — intervention group
Group type: EXPERIMENTAL
Intervention: Melphalan 40 mg/m2 (n = 6)
Number of subjects: 21
Study 10656432 — intervention group
Group type: EXPERIMENTAL
Intervention: Melphalan (all doses)
Number of subjects: 21
Study 8882244 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 5.0 micrograms.kg‐1
Number of subjects: 60
Study 8882244 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 0.625 micrograms.kg‐1
Number of subjects: 60
Study 8882244 — intervention group
Group type: COMPARATOR
Intervention: Control group (no fentanyl)
Number of subjects: 60
Study 1993621 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged treatment elapsed days (14 days beyond the protocol prescription)
Number of subjects: 426
Study 1993621 — intervention group
Group type: EXPERIMENTAL
Intervention: Revised criteria for unacceptable overall treatment including prolonged elapsed treatment days
Number of subjects: 426
Study 31600424 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based lifestyle intervention (details on dosage and duration not available)
Number of subjects: 46
Study 31600424 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative feedback on intervention prototypes
Number of subjects: 46
Study 30934066 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab (500 mg/m2, 2 infusions 2 weeks apart, followed by 4 maintenance infusions of 500 mg at 3, 6, 9, and 12 months)
Number of subjects: 151
Study 30934066 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study 30934066 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 151
Study 28671088 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycoplasma pneumoniae infection
Number of subjects: 0
Study 25537254 — intervention group
Group type: EXPERIMENTAL
Intervention: Movement restriction (wearing a sling)
Number of subjects: 40
Study 25537254 — intervention group
Group type: COMPARATOR
Intervention: Control (not wearing a sling)
Number of subjects: 40
Study 25537254 — intervention group
Group type: EXPERIMENTAL
Intervention: Movement restriction
Number of subjects: 40
Study 23620150 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratympanic dexamethasone injections (ITDI)
Number of subjects: 30
Study 23620150 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 30
Study 21859417 — intervention group
Group type: EXPERIMENTAL
Intervention: chronoFLO4
Number of subjects: 556
Study 21859417 — intervention group
Group type: COMPARATOR
Intervention: FOLFOX2
Number of subjects: 556
Study 19959960 — intervention group
Group type: EXPERIMENTAL
Intervention: Botox (300 U)
Number of subjects: 24
Study 19959960 — intervention group
Group type: EXPERIMENTAL
Intervention: Prosigne (300 U)
Number of subjects: 24
Study 17425756 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone dosage higher than 20 mg/d
Number of subjects: 25
Study 17425756 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroids administration
Number of subjects: 25
Study 17425756 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroids therapy
Number of subjects: 25
Study 16390019 — intervention group
Group type: EXPERIMENTAL
Intervention: Gated perfusion SPECT (GPS)
Number of subjects: 36
Study 16390019 — intervention group
Group type: COMPARATOR
Intervention: Radionuclide ventriculography (RVG)
Number of subjects: 36
Study 16390019 — intervention group
Group type: COMPARATOR
Intervention: Comparison of EF difference between RVG and GPS
Number of subjects: 36
Study 16390019 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold defect number (CDN)
Number of subjects: 36
Study 16390019 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold perfusion defects (CD%) and infarcted segments (IS%)
Number of subjects: 36
Study 12471401 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized measles vaccine (Edmonston-Zagreb)
Number of subjects: 5
Study 12471401 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized measles-rubella vaccine (Edmonston-Zagreb with RA27/3)
Number of subjects: 5
Study 12471401 — intervention group
Group type: COMPARATOR
Intervention: Injected measles vaccine (Edmonston-Zagreb)
Number of subjects: 5
Study 12471401 — intervention group
Group type: COMPARATOR
Intervention: Injected measles-rubella vaccine (Edmonston-Zagreb with RA27/3)
Number of subjects: 5
Study 12471401 — intervention group
Group type: COMPARATOR
Intervention: Injected Schwarz measles vaccine
Number of subjects: 5
Study 12471401 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized measles vaccine (1000 plaque-forming units of Edmonston-Zagreb)
Number of subjects: 5
Study 9579001 — intervention group
Group type: COMPARATOR
Intervention: High/Scope Perry Preschool study participants
Number of subjects: 0
Study 9579001 — intervention group
Group type: EXPERIMENTAL
Intervention: High-quality early education programs
Number of subjects: 0
Study 9579001 — intervention group
Group type: COMPARATOR
Intervention: Highly intensive academic program participants
Number of subjects: 0
Study 9579001 — intervention group
Group type: EXPERIMENTAL
Intervention: Investment in educational intervention
Number of subjects: 0
Study 9345396 — intervention group
Group type: EXPERIMENTAL
Intervention: rIFN-alpha (9 MIU, intramuscularly every other day for 6 months)
Number of subjects: 20
Study 9345396 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 2713577 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine
Number of subjects: 0
Study 329085 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (80 to 120 mg per day)
Number of subjects: 18
Study 329085 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 31280058 — intervention group
Group type: EXPERIMENTAL
Intervention: Encoding immediately after acute stress
Number of subjects: 100
Study 31280058 — intervention group
Group type: EXPERIMENTAL
Intervention: Encoding two hours after acute stress
Number of subjects: 100
Study 31280058 — intervention group
Group type: COMPARATOR
Intervention: Control group (encoding without stress)
Number of subjects: 100
Study 28254205 — intervention group
Group type: EXPERIMENTAL
Intervention: Family delivered intervention including orientation or memory clues, sensory checks, and cognitive stimulation
Number of subjects: 61